tACS applies a low-intensity alternating current across the scalp with the intention of entraining or modulating endogenous brain oscillations at a targeted frequency. The mechanism is biophysically interesting and actively studied, but the evidence base sits largely at the pilot and protocol stage, and reported effects are inconsistent across studies. A representative protocol for post-stroke depression explicitly notes a lack of robust replicated results, and the field overall reports frequent replication and state-dependence problems. Findings should be read as preliminary rather than established.
Origin & lineage
tACS descends from transcranial electrical stimulation (tES) research and was developed as the oscillatory variant of weak scalp-applied current, delivering an alternating (sinusoidal) waveform at a chosen frequency rather than the steady offset used in tDCS.
Claimed mechanism
A sinusoidal current at a target frequency is delivered between scalp electrodes with the aim of entraining or modulating cortical oscillations at that frequency. Dose is described by amplitude (current intensity), stimulation frequency, relative phase, and electrode montage. The precise neural mechanism is acknowledged to be incompletely understood.
Plausibility
Plausible–weak, early/under study — oscillation entrainment is biophysically reasonable but the effect appears small and state-dependent.
Evidence — grade C/D
Graded C/D because the oscillation-entrainment rationale is mechanistically plausible yet supporting trials are small, frequently fail to replicate, and show strong dependence on individual brain state and stimulation parameters. Much of the published work is at the protocol or pilot stage rather than confirmatory, so efficacy for specific indications remains unestablished.
Cross-reference
Distinct from tDCS (which delivers direct rather than alternating current) and from taVNS (vagus-nerve stimulation); within the broader Electroceuticals family.
Market
Makers: Research-grade tES systems are supplied by vendors such as Neuroelectrics and Soterix Medical (cited as class examples, not endorsements). Models: Programmable multi-channel tES/tACS stimulators used in research settings (class examples; specific cleared indications vary by jurisdiction and are not asserted here). Price: Not specified in source.
Kernel — keep vs set aside
Keep — real substrate
Keep the core question — whether weak alternating currents can entrain or modulate endogenous cortical oscillations to produce reproducible functional effects — as a legitimate and ongoing research program.
Set aside — claim
Set aside consumer-grade 'brainwave-tuning' or cognitive-enhancement marketing claims, and do not treat the existence of a clinical-trial registration as evidence that the intervention works.
Regulatory status by jurisdiction
Registration or clearance is a market-access fact, never proof of efficacy.
US — FDA
Not specified in source. Reviewed sources describe investigational/research use; a clinical-trial registration is not an FDA clearance.
The NCT07185464 entry is a trial registration (status: not yet recruiting, no results posted) and is not evidence of efficacy. The PMC7220515 item is a study protocol representing early-stage rather than confirmatory evidence.